First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid ‘shot’ form, announced today that it has completed a Series B financing round.  Sofinnova Ventures and Redmile Group co-led the round with additional support from investors including HealthQuest Capital.

 F.A.S.T.’s products are OTC pharmaceutical based single serve liquid medicines that meet the applicable OTC monograph and are intended to treat everyday conditions such as pain and upset stomach. Additional products aimed at a broad range of consumer needs are being developed and will be launched in due course.

Read More